isoproterenol has been researched along with mdl 100907 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callebert, J; Etienne, N; Jaffré, F; Launay, JM; Maroteaux, L; Monassier, L; Nebigil, CG; Sarre, A | 1 |
| Birkeland, JA; Enger, U; Levy, FO; Lunde, PK; Qvigstad, E; Sejersted, OM; Sjaastad, I; Swift, F; Tovsrud, N | 1 |
| Blaxall, BC; Bonnin, P; Callebert, J; Debbabi, H; Doly, S; Jaffré, F; Launay, JM; Maroteaux, L; Mettauer, B; Monassier, L; Setola, V | 1 |
| Shyu, KG | 1 |
| Davern, PJ; McKinley, MJ | 1 |
| Al-Attas, OS; Arya, DS; Bharti, S; Chauhan, SS; Hussain, T; Singh, R | 1 |
6 other study(ies) available for isoproterenol and mdl 100907
| Article | Year |
|---|---|
Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Cardiomegaly; Cells, Cultured; Drug Evaluation, Preclinical; Fibroblasts; Gene Expression Regulation; Heart Ventricles; Imidazoles; Indoles; Interleukin-1; Interleukin-6; Isoproterenol; Mice; Mice, Knockout; Myocytes, Cardiac; Propanolamines; Pyridines; Quinolines; Receptor, Serotonin, 5-HT2B; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sympathetic Nervous System; Sympathomimetics; Tumor Necrosis Factor-alpha | 2004 |
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium Channels, L-Type; Calcium Signaling; Calcium-Binding Proteins; Cardiac Myosins; Cardiotonic Agents; Coronary Vessels; Disease Models, Animal; Heart Failure; Indoles; Isoproterenol; Ketanserin; Ligation; Male; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Myosin Light Chains; Phosphorylation; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT4; Sarcoplasmic Reticulum; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Sulfonamides; Time Factors; Troponin I; Ventricular Function | 2007 |
Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
Topics: Adult; Angiotensin II; Animals; Cells, Cultured; Cytokines; ErbB Receptors; Female; Fibroblasts; Heart Failure; Heparin-binding EGF-like Growth Factor; Humans; Hypertrophy, Left Ventricular; Intercellular Signaling Peptides and Proteins; Isoproterenol; Male; Mice; Mice, Knockout; Mice, Transgenic; Middle Aged; Myocardium; Myocytes, Cardiac; Norepinephrine; Protein Interaction Mapping; Receptor, Angiotensin, Type 1; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; src-Family Kinases | 2009 |
Serotonin 5-HT2B receptor in cardiac fibroblast contributes to cardiac hypertrophy: a new therapeutic target for heart failure?
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Cytokines; Drug Delivery Systems; ErbB Receptors; Fibroblasts; Heart Failure; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Isoproterenol; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Transgenic; Myocardium; Rats; Receptor, Angiotensin, Type 1; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Signal Transduction | 2009 |
Forebrain regions affected by lateral parabrachial nucleus serotonergic mechanisms that influence sodium appetite.
Topics: Adrenergic beta-Agonists; Animals; Appetite Regulation; Drinking; Injections, Intraventricular; Injections, Subcutaneous; Isoproterenol; Male; Methysergide; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred WF; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Rhombencephalon; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sodium Chloride; Water | 2010 |
Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats.
Topics: Animals; Cardiomegaly; Drug Evaluation, Preclinical; Drug Synergism; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Isoproterenol; Male; Maleimides; Myocardium; Nitric Oxide Synthase Type III; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Thiophenes | 2012 |